Printer Friendly
The Free Library
14,508,364 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Research and Markets: Roche and Affymetrix Were the First to Receive FDA Clearance for A Biochip-Based Molecular Diagnostic Test and Instrument System - '2007 The Worldwide Biochip & Equipment Market'.


DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c45548) has announced the addition of 2007 The Worldwide Biochip biochip

Small-scale device, analogous to an integrated circuit, constructed of or used to analyze organic molecules associated with living organisms. One type of theoretical biochip is a small device constructed of large organic molecules, such as proteins, and capable of
 & Equipment Market (Japanese Version) to their offering.

This report provides a broad review of the dynamic worldwide biochip business. Biochips are becoming more diverse and customers from North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. , Europe and Asia are demanding these products. The products from the biochip market are being used to help accelerate the research processes and capabilities of bio-pharmaceutical drug discovery, diagnostics and basic academic medical research.

In recent history, the big pharma companies have suffered increasing R&D costs while their actual output of new drugs has declined. Drug companies needed to look outside of their companies to find drug products faster. As a result, pharma companies have increasingly become motivated research and financial partners with many biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies.
. Pharma companies also want to become customers and partners of biochip companies because these companies have technologies that might help them become more productive faster.

Concepts such as pharmacogenomics Pharmacogenomics is the branch of pharmacology which deals with the influence of genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with a drug's efficacy or toxicity.  and targeted therapies have become accepted ideas by government regulators. Roche and Affymetrix were the first to receive FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 clearance for a biochip-based molecular diagnostic test and instrument system.

Basic academic research is helping too. Accelerating the drug making process requires modern industrialization industrialization

Process of converting to a socioeconomic order in which industry is dominant. The changes that took place in Britain during the Industrial Revolution of the late 18th and 19th century led the way for the early industrializing nations of western Europe and
 of R&D by using genomics and proteomics technologies such as biochips that the biotechnology companies provide.

This report discusses these important topics with interesting findings. New data is presented that calculates that the total biochip market size is projected to grow to about $4 billion in 2010 with a CAGR CAGR

See: Compound Annual Growth Rate
 of 12.1%. It reviewed the activities of 26 companies. This report uses more than 60 figures and tables to illustrate the findings. This report features 5 at-a-glance tables at the start of each biochip section to help the reader zoom into details quickly.

Section Outline:

Section A: Executive Summary

Section B: DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
 Biochips, Equipment, Content and Services

Section C: Lab-on-a-chip Biochips and Equipment

Section D: Protein Biochips and Equipment

Section E: Special Purpose Biochips and Equipment

Section F: Activities/ Profiles of Major Biochip Companies

Section G: Important Findings and New Business Opportunity Areas

Section H: Appendix - Company Contact Information by Category

List of Tables

List of Figures

For more information visit http://www.researchandmarkets.com/reports/c45548
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 20, 2006
Words:377
Previous Article:Telecom Industry Leader Named as Advisor To SS8 Networks.
Next Article:Research and Markets: The Company Alfa Romeo's Major Customers Worldwide and a Round-Up of Recently Awarded Supply Contracts.
Topics:



Related Articles
Acacia Research Subsidiary, CombiMatrix, Completes Major Milestone in Strategic Alliance with Roche.
Roche Diagnostics' Next Generation Automated PCR System, the COBAS TaqMan Analyzer, Now Available for Commercial Use.
Epigenomics AG and Affymetrix Announce Strategic Diagnostics Platform Agreement.
Expression Analysis Announces Additions to its Scientific Advisory Board.
Wyeth Extends Agreement with Affymetrix to 15 Years.
Gain An Insight In To Dynamic Worldwide Biochip Business.
Affymetrix and Sysmex Join Forces to Develop and Market In-Vitro Diagnostic Tests.
IRIS Submits 510(k) Application To FDA For Its N.A.D.I.A. Prostate Cancer Test.
New FDA Initiatives to Accelerate the Approval of Emerging Diagnostics and Drugs.
LabCorp to Be First Commercial Laboratory to Offer FDA Approved, Fully Automated Real-Time HIV Test from Roche Diagnostics.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles